Category: pharma marketing through social media
Earlier this week, LiveWorld held its first social media lunch and learn event in Bridgewater, New Jersey. Modeled from the success of a similar event at Social Media Week 2013, the event brought together an intimate group of like-minded marketing professionals for a case study presentation and panel discussion over lunch. Zoetis kicked off the […]
@Spitz interviews Jay Bryant, Vice President of Sales at LiveWorld at the Digital Pharma East Conference in Philadelphia, October 15-18, 2012.
Following a discussion that he led at the BDI Social Communications & Healthcare 2011 roundtables last week, our LiveWorld Sales VP, Jay Bryant, checks in with Pixels & Pills’ Sarah for a conversation about social media’s impact on the pharmaceutical industry. In the interview, Jay addresses the concern that many pharma brands raise as they participate in social […]
August 15, 2011 looms as the date when disease-state and over-the-counter (OTC) pharma brands will no longer be able to prevent fans from commenting on their Facebook Pages. This also means an obligation to watch for and report all adverse events (AE) on the Page. So how much AE content should pharma brands realistically expect? To […]
Changes are coming to Facebook that will require pharma companies to allow fan comments on their Wall posts. And in the presentation below, LiveWorld Chief Community Officer Jenna Woodul shares how pharma marketers should prepare for this new two-way environment. Pharma Facebook Changes View more presentations from LiveWorld —— This post is part […]
Facebook has decided to no longer allow pharma companies to “whitelist” their Pages. What this means: Up until now, pharma companies with Facebook Pages could request that Facebook disable the ability for people to comment on and/or Like brand posts. This exception should not be confused with the ability every Page has to disable the capability for […]